Abnormal renovascular reactivity, characterized by paradoxical vasoconstriction to a reduction in renal perfusion pressure (RPP) in the autoregulatory range, increased sensitivity to renal nerve stimulation (RNS), and loss of vasodilatation to acetylcholine have all been demonstrated in ischemic acute renal failure (ARF). To determine if ischemic injury alters vascular contractility by increasing smooth muscle cell calcium or calcium influx, the renal blood flow (RBF) response to reductions in RPP within the autoregulatory range and to RNS were tested before and after a 90-min intrarenal infusion of verapamil or diltiazem in 7-d ischemic ARF rats. Both calcium entry blockers, verapamil and diltiazem, blocked the aberrant vasoconstrictor response to a reduction in RPP and RNS (both P < 0.001).
Introduction
The pathogenesis of ischemic acute renal failure (ARF)' involves both tubular and vascular abnormalities (1) (2) (3) (4) . In reThis study has previously appeared in abstract form (1986. Proc. Am. Soc. Nephrol. 19:217A.) . cent years, the tubular abnormalities have been intensively studied (5) (6) (7) (8) , while the vascular abnormalities have received less attention (9, 10) . It has become clear, however, that an ischemic renal injury sufficient to cause reversible ARF is associated with abnormal renovascular reactivity in both the dog (10) and rat (9) . Paradoxical vasoconstriction to a reduction in renal perfusion pressure (RPP) in the normal autoregulatory range, hypersensitivity to renal nerve stimulation (RNS), and loss of the renal vasodilatory effect of acetylcholine have been described (9) . These vascular phenomena have been proposed to provide a potential explanation for the clinical observation that fresh tubular necrotic lesions have been demonstrable in renal tissues as late as 4 wk after the overt clinical episode causing the ARF (1 1). Thus, subclinical ischemic episodes may cause tubular necrosis in a kidney recovering from ARF because of a renal vasoconstriction to relatively small reductions in RPP, hypersensitivity to RNS, and loss of renal vasodilatory influences. Support for this possibility has been reported recently in the rat where transient reduction in mean RPP from 120 to 90 mmHg caused recurrent azotemia and fresh areas of necrosis in ARF rats (12) .
The present study was undertaken to further examine the vascular abnormalities of experimental ARF. On the basis of the morphological evidence of vascular damage associated with renal ischemic injury (13) , the hypothesis was examined that the abnormal pressor response to a reduction in RPP in the normal autoregulatory range, and hypersensitivity to RNS involved an increase in cellular calcium analogous to that which occurs in the renal tubule during the reflow phase of ischemic ARF (6) . In this regard, an increase in cellular calcium and the calcium-calmodulin complex are important in the contractile process of vascular smooth muscle (14) . To test this hypothesis, the effects of two chemically dissimilar calcium entry blockers (CEB) on the pressor response to a reduction in RPP and RNS in 7-d ischemic ARF rats were examined. Moreover, the possibility was examined that the absence of the vasodilatory response to acetylcholine in ischemic ARF was due to endothelial damage and loss of endothelium-derived relaxing factor (EDRF) activity (15) , as it has been reported to be the case in the postischemic coronary circulation (16) . An absence of response to EDRF may effectively be similar to removing the attenuating effect of endothelium in renovascular reactivity (17) . The renal response to EDRF-dependent and -independent vasodilators was examined in 7-d ischemic ARF rats.
Methods
The disease model, NE-induced ARF, has been described previously (18 24 and 48 h after NE infusion, remained stable over the next 3 d, and fell gradually to control levels over the next 14-20 d (18) . Renal blood flow (RBF) fell to zero at the time of NE infusion, returned to 70% of control levels by 24 h, and gradually rose to control levels by 1 wk. Inulin clearance (CIN) fell to zero after NE infusion and slowly rose to 40% of control at 1 wk and 85% of control by 3 wk. Oliguria relative to control was present for 48 h after NE infusion and varied from continued oliguria to polyuria thereafter ( 19) .
The technique of measuring renal vascular reactivity was described previously (9) and carried out as follows: at 1 wk, the rats were anesthetized with pentobarbital, 60 mg/kg i.p. after solid food had been withheld overnight. An endotracheal tube was positioned and catheters were placed in the right jugular vein and the femoral artery. The left kidney was exposed through a flank incision, the renal artery dissected bluntly from the renal vein, and a catheter was placed in the ureter. Blood pressure was measured through the right femoral artery catheter, which was connected to an electronic transducer (PD23DE; Statham Instruments, Oxnard, CA), and a direct-writing recorder (7702B; Hewlett-Packard Co., Palo Alto, CA). Ringer's lactate, containing an amount of inulin sufficient to give plasma concentrations of 50-100 mg/dl, was infused at 2 ml/h through thejugular venous catheter. After 1 h of equilibration, blood and urine samples were collected for CIN measurements. Spontaneous systemic blood pressures were in the range of 120-126 mmHg in ARF rats. RPP was controlled by placing a pliable small-gauge platinum wire about the aorta above the renal artery. Alterations in RBF were determined at RPP of 120, 110, 100, and 90 mmHg. The autoregulatory range of RBF in the rat has previously been demonstrated to be between 90 and 140 mmHg (20) . The RBF was measured with a miniature flow probe (Carolina Medical Electronics, Inc., King, NC), which was placed around the renal artery and attached to a digital recorder. The flow probe calibration was conducted according to the method ofArendshorst et al. (21) . RBF was recorded 2 min after RPP was stabilized at each respective pressure. Measurements were made in duplicate.
After determinations ofthe RBF response to reduction in RPP, the effect of RNS on RBF was measured. The left renal nerve bundle was isolated near the aorta, crushed centrally and placed over a small insulated stainless steel hook electrode for nerve stimulation with a stimulus isolation unit (SIU5; Grass Instrument Co., Quincy, MA) (9). The nerve bundle was isolated by surrounding it with a Parafilm sheet for a distance of I cm. Stimulator settings were as follows: electromotive forces 3 V, duration of 50 ms, delay 50 ms, frequency of stimulation from 0 to 10 Hz at 2-Hz intervals. RBF was recorded after 2 min of stimulation. It was allowed to return to control between stimulation periods.
Protocol 1 Effect ofCEBs. 12 uninephrectomized rats were prepared for ischemic ARF induction with NE given directly into the renal artery as described above. 12 additional rats were similarly prepared but were given 0.9% saline rather than NE at the same rate. 1 wk later, both NE-ARF and sham-ARF control rats were prepared for reduction in RPP and RNS experiments as described above. RBF responses to baseline and serial reduction in RPP and RNS were then determined as control responses. After these measurements, the renal artery infusion was changed to verapamil, 6.0 ,g/kg per min-' in six NE-ARF and six control rats, or to diltiazem, 4.7 X 10-2 gg/kg per min-', in six NE-ARF and six control rats. The infusion doses were the maximal intrarenal doses that did not alter systemic hemodynamics. After 90 min, RBF responses to reduction in RPP and RNS were repeated while the CEB infusion was continued.
In six additional NE-ARF rats, prostacyclin (PGI2 The RBF responses to RNS in sham-ARF control rats are shown in Fig. 3 . The slope of the preinfusion RBF to progressive stimulation was 0.17±0.05 ml/Hz. Verapamil infusion effectively blocked the vasoconstrictor response to RNS (slope 1.01±0.02 ml/Hz; P < 0.001 compared with the preinfusion value). Diltiazem also attenuated the preinfusion response to RNS (slope 0.04±0.02 ml/Hz, P < 0.001).
In Fig. 4 the RBF responses to RNS before and after verapamil or diltiazem infusion in NE-ARF rats are illustrated. The vasoconstriction to progressive increments in RNS frequency before CEB infusion was significantly greater than the corresponding response to RNS in sham-ARF control rats (P < 0.001). Vasoconstriction to RNS in NE-ARF rats was similarly blunted by either verapamil or diltiazem. The preinfusion slope was 0.56±0.08 ml/Hz; with verapamil it was 0.02±0.01 ml/Hz, and with diltiazem it was 0.07±0.08 ml/Hz. The slopes with verapamil and diltiazem were significantly less than the respective preinfusion slopes at P < 0.001. Before RNS, at a baseline RPP of 120 mmHg, preinfusion RBF was 8.40±0.50 ml/min; during verapamil, 9.40±0.90 ml/min, and during diltiazem, 9 .70±1.20 ml/min. RBF after verapamil and diltiazem Progressive increases in RNS decreased RBF to the same extent whether in the absence or presence of the EDRF-dependent vasodilators, acetylcholine and bradykinin (Fig. 6) . The intercepts and slopes for acetylcholine (8.50±0 .50 ml/min and 0.60±0.09 ml/Hz) and bradykinin (8.85±0.46 ml/min and 0.65±0.15 ml/Hz) were not different from the preinfusion values (8.40±0.50 ml/min and 0.56±0.08 ml/Hz). While the EDRF-independent vasodilator, PGI2, increased the level of RBF at each level of RNS, the slope of the response was actually slightly greater than the preinfusion value. The respective intercepts were 8.40±0.50 ml/min preinfusion and 11.30±0.87 ml/min during PGI2 (different at P < 0.001). The slopes were 0.56±0.08 ml/Hz preinfusion and 0.84±0.19 ml/Hz (different at P < 0.05). 
Discussion
Although RBF is maintained at a reasonable level (50-75% of normal) even in the presence of ARF (18), it is nevertheless possible that persistent vascular abnormalities may contribute to the duration of ARF before recovery. Specifically, the paradoxical renal vasoconstrictor response to reduction in RPP and hypersensitivity to RNS could mediate recurrent tubular necrosis and thus sustain persistent tubular dysfunction during the maintenance phase of ARE. Thus, subclinical alterations in systemic blood pressure, which would not affect renal perfusion in normal physiologic circumstances, could cause renal ischemia and tubular necrosis in the ARF kidney, which exhibits vasoconstriction to reduction in RPP in the normal autoregulatory range and hypersensitivity to RNS. Indeed, the documentation that fresh tubular necrosis may be observed as late as 4 wk after the onset of ARF in patients (11) is compatible with this possibility. Moreover, the observation that in 7-d NE-induced ARF rats a lowering of RPP within the autoregulatory range is associated with tubular necrosis and the worsening of azotemia, while no detectable changes occur in normal rats, also supports this possibility (12) . Since intracellular calcium is known to be an important mediator ofvascular contractility (14) , and CEBs are known to attenuate experimental ARF in animals (22) as well as enhance cadaver graft survival in patients (23) , the possibility exists that some ofthe vascular abnormalities in ischemic ARF may be modulated by perturbations in cell calcium. The recent observation that ischemic injury to the kidney is associated with vascular damage (13) is compatible with the recent suggestion that enhanced intracellular calcium influx alters renal vascular tone and responsiveness in ischemic ARF (5) . An alternative or additional pathological result of ischemia-induced vascular damage might, however, be that endogenous EDRF-dependent renal vasodilators such as acetylcholine and bradykinin are not able to modify ischemic insults in the ARF kidney, which is similar to the recent observations that have been made with acetylcholine in the postischemic coronary circulation (16) . The observation in the present study that two chemically different CEBs, verapamil and diltiazem, afford protection against some of the vascular abnormalities associated with ischemic ARF is compatible both with the role of cellular calcium in these vascular smooth muscle abnormalities of ischemic ARF as well as with a vascular role for CEBs in preventing experimental ischemic ARF. In this regard, it has been suggested that a vascular rather than a cytoprotective tubular effect mediates the in vivo protective effect of CEBs against ischemic ARF (24) . While the present results do not exclude the possibility of a solitary effect of CEBs on tubular epithelium, a possibility for which there is considerable evidence, these findings are clearly in support of important vascular effects of these agents in the attenuation of ischemic ARF. As with the protective effect against ischemic ARF, the intrarenal delivery and the duration of the infusion of the CEBs are of potential importance. In the present study, 90, but not 30, min of intrarenal verapamil or diltiazem blocked the renal vasoconstrictor response to reduction in RPP and attenuated the hypersensitivity to RNS. Similarly, in a previous study, 2 h, but not 30 min, of intrarenal verapamil or nifedipine attenuated ischemic ARF induced by NE in the dog (22) . Also of interest is the observation that intrarenal CEBs decrease tubular sodium reabsorption in the normal dog (25) , whereas the known diminution in tubular sodium reabsorption associated with ischemic ARF is significantly attenuated by CEBs (26) . Such observations are compatible with profoundly different cellular calcium kinetics in normal, as compared with ischemically injured, vascular smooth muscle and tubular epithelium.
It must be pointed out that while verapamil and diltiazem blocked the renal vasoconstrictor response in the NE-ARF rats, these agents had little effect on normal RBF autoregulation in the sham-ARF control rats. While there was a progressive decline in RVR with reduction in RPP in the sham-ARF control rats before CEB infusion, this fall in RVR was significantly attenuated by verapamil and diltiazem. The RVR changes that occur with a reduction in RPP during verapamil and diltiazem infusion in NE-ARF rats were also less than those of the preinfusion decline in RVR in sham-ARF controls. CEBs have been shown by others to reduce autoregulatory capacity in rat and dog kidneys (27, 28) . Nevertheless, the striking effect of the CEB was that these agents blocked the paradoxical renal vasoconstriction to reduction in RPP in NE-ARF rats. Lastly, it should be noted that the ability of PGI2 to increase RBF in verapamil-infused kidneys in this study indicates that there was potential for further vasodilatation in the CEB-infused kidneys with reduction in RPP.
The present results also provide a potential explanation for the previous observation that ischemia-induced ARF kidneys in the rat do not respond to acetylcholine (9) . Since the vasodilator effect of acetylcholine is dependent upon the presence of an endothelium-derived substance (EDRF) (15, 29) and the renal vascular endothelium is injured after an acute ischemic insult (13), failure to synthesize or release EDRF could potentially mediate this resistance to acetylcholine. The observation that bradykinin, another EDRF-dependent vasodilator (30), also did not increase RBF in the ischemic ARF kidneys provided further support for this possibility. Moreover, PGI2, an EDRF-independent vasodilator (15), was shown to vasodilate the ARF kidneys. These findings also supported the possibility of a unique role for CEBs in the above described vascular abnormality of ischemic ARF. Although PGI2 caused vasodilatation in this setting, it did not block the vasoconstrictor response to reduction in RPP in the ARF rats. The potential importance of preservation of the vasodilatory response to PGI2 in the ischemically injured kidney, is supported by the observations that inhibition of prostaglandin synthesis may cause ARF in settings such as cirrhosis (31) , cardiac failure (32) , volume depletion (33) , and lupus nephritis (34); circumstances known to be associated with increased renal vascular resistance.
In conclusion, the observations that two chemically dissimilar CEBs abolished the paradoxical vasoconstriction to reduction in RPP and hypersensitivity to RNS in ischemic ARF support a role ofperturbation in vascular smooth muscle cellular calcium in the pathogenesis of these vascular abnormalities. These findings suggest that the protective effect of CEBs against ischemic ARF may be mediated, at least in part, by effects of vascular smooth muscle. The endothelial damage associated with ischemic ARF is also of importance because the response to endogenous EDRF-dependent renal vasodilators such as acetylcholine and bradykinin is impaired, while the response to the EDRF-independent, endogenous renal vasodilator, prostacyclin, is preserved.
